COPE-ICD: A randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and population-Reference-Cited by-同舟云学术

COPE-ICD: A randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and population

Published:2011-06-17 Issue:1 Volume:11 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Berg Selina K,Svendsen Jesper H,Zwisler Ann-Dorthe,Pedersen Birthe D,Preisler Pernille,Siersbæk-Hansen Lone,Hansen Mette B,Nielsen Rune H,Pedersen Preben U

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/article/10.1186/1471-2261-11-33/fulltext.html

Reference50 articles.

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, American College of Cardiology American Heart Association Task Force European Society of Cardiology Committee for Practice Guidelines European Heart Rhythm Association Heart Rhythm Society: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006, 8: 746-837.

2. Al-Khatib SM, Sanders GD, Carlson M, Cicic A, Curtis A, Fonarow GC, Groeneveld PW, Hayes D, Heidenreich P, Mark D, Peterson E, Prystowsky EN, Sager P, Salive ME, Thomas K, Yancy CW, Zareba W, Zipes D: Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. Am Heart J. 2008, 156: 613-622. 10.1016/j.ahj.2008.05.027.

3. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M: Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation. 2000, 101: 1660-1664.

4. Thomas SA, Friedmann E, Kelley FJ: Living with an implantable cardioverter-defibrillator: a review of the current literature related to psychosocial factors. AACN Clin Issues. 2001, 12: 156-163. 10.1097/00044067-200102000-00015.

5. Sears SF, Todaro JF, Lewis TS, Sotile W, Conti JB: Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol. 1999, 22: 481-489. 10.1002/clc.4960220709.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life, depression, and anxiety in patients with a subcutaneous versus transvenous defibrillator system;Pacing and Clinical Electrophysiology;2019-11-17

2. Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator;Cochrane Database of Systematic Reviews;2019-02-12

3. Sexual Counseling Provided by Cardiovascular Nurses;Journal of Cardiovascular Nursing;2018-11

4. Employment Status and Sick Leave After First-Time Implantable Cardioverter Defibrillator Implantation;Journal of Cardiovascular Nursing;2017-09

5. Complications of Heart Rhythm Management Devices After Cardiac Rehabilitation Program;Clinical Nurse Specialist;2017-05